191 related articles for article (PubMed ID: 31105791)
1. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.
Fu X; Tian Y; Kuang W; Wen S; Guo W
Exp Ther Med; 2019 Jun; 17(6):4715-4722. PubMed ID: 31105791
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
3. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T
Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379
[TBL] [Abstract][Full Text] [Related]
4. Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer.
Zhang X; Guo H; Bao Y; Yu H; Xie D; Wang X
Oncol Lett; 2019 Nov; 18(5):5197-5204. PubMed ID: 31612030
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Zhao Z; Liang S; Sun F
Front Oncol; 2020; 10():1172. PubMed ID: 32850336
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
[TBL] [Abstract][Full Text] [Related]
8. Promising long noncoding RNA DLX6-AS1 in malignant tumors.
Xue C; Lv L; Jiang J; Li L
Am J Transl Res; 2020; 12(12):7682-7692. PubMed ID: 33437353
[TBL] [Abstract][Full Text] [Related]
9. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
Wu Q; Ma J; Meng W; Hui P
Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
You Q; Shi HY; Gong CF; Tian XY; Li S
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6429-6435. PubMed ID: 31378881
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10867-10873. PubMed ID: 31858555
[TBL] [Abstract][Full Text] [Related]
12. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
Li J; Li P; Zhao W; Yang R; Chen S; Bai Y; Dun S; Chen X; Du Y; Wang Y; Zang W; Zhao G; Zhang G
Cancer Cell Int; 2015; 15():48. PubMed ID: 26052251
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA AFAP1-antisense RNA 1 promotes the proliferation, migration and invasion of gastric cancer cells and is associated with poor patient survival.
Zhao H; Zhang K; Wang T; Cui J; Xi H; Wang Y; Song Y; Zhao X; Wei B; Chen L
Oncol Lett; 2018 Jun; 15(6):8620-8626. PubMed ID: 29805596
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.
Li Z; Ding Z; Rong D; Tang W; Cao H
Oncol Lett; 2019 Sep; 18(3):3211-3217. PubMed ID: 31452798
[TBL] [Abstract][Full Text] [Related]
15. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
16. DLX6-AS1: A Long Non-coding RNA With Oncogenic Features.
Ghafouri-Fard S; Najafi S; Hussen BM; Ganjo AR; Taheri M; Samadian M
Front Cell Dev Biol; 2022; 10():746443. PubMed ID: 35281110
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.
Zhang N; Meng X; Mei L; Zhao C; Chen W
J Cell Biochem; 2019 Jul; 120(7):11478-11489. PubMed ID: 30838699
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
20. LncRNA
Sun W; Zhang L; Yan R; Yang Y; Meng X
Onco Targets Ther; 2019; 12():3945-3954. PubMed ID: 31190891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
